// App-Quantinova.ai

e22510 : The role and optimal duration of adjuvant imatinib therapy in primary GIST patients.

Researchers

Presenter

  • Peter Arkhiri

Principal Investigators

  • Ivan S. Stilidi

  • Irina Poddubnaya

  • Sergey N. Nered

  • Vahan Yurikovich Bokhian

  • Ivan N. Peregorodiev

  • Maxim P. Nikulin

Medical Centers

  • N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Gastrointestinal stromal tumor

Biomarkers

  • N/A

Drug/Treatment

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved